These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14636027)

  • 1. A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies.
    Plank MJ; Sleeman BD
    Math Med Biol; 2003 Jun; 20(2):135-81. PubMed ID: 14636027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.
    Levine HA; Pamuk S; Sleeman BD; Nilsen-Hamilton M
    Bull Math Biol; 2001 Sep; 63(5):801-63. PubMed ID: 11565406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the angiopoietins in tumour angiogenesis.
    Plank MJ; Sleeman BD; Jones PF
    Growth Factors; 2004 Mar; 22(1):1-11. PubMed ID: 15179939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numerical simulation of the inhibitory effect of angiostatin on metastatic tumor angiogenesis and microenvironment.
    Zhao G; Yan W; Chen E; Yu X; Cai W
    Bull Math Biol; 2013 Feb; 75(2):274-87. PubMed ID: 23292363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.
    Tee D; DiStefano J
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):15-24. PubMed ID: 14586644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2D mathematical model for tumor angiogenesis: The roles of certain cells in the extra cellular matrix.
    Pamuk S; Çay İ; Sazcı A
    Math Biosci; 2018 Dec; 306():32-48. PubMed ID: 30393207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lattice and non-lattice models of tumour angiogenesis.
    Plank MJ; Sleeman BD
    Bull Math Biol; 2004 Nov; 66(6):1785-819. PubMed ID: 15522355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model for capillary formation and development in tumor angiogenesis: a review.
    Pamuk S
    Chemotherapy; 2006; 52(1):35-7. PubMed ID: 16340197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.
    Plank MJ; Sleeman BD; Jones PF
    J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human Angiostatin protein on human angiogenesis in vitro.
    Jung SP; Siegrist B; Wang YZ; Wade MR; Anthony CT; Hornick C; Woltering EA
    Angiogenesis; 2003; 6(3):233-40. PubMed ID: 15041799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis inhibitors and the need for anti-angiogenic therapeutics.
    Dass CR; Tran TM; Choong PF
    J Dent Res; 2007 Oct; 86(10):927-36. PubMed ID: 17890668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis.
    Hutchinson LG; Gaffney EA; Maini PK; Wagg J; Phipps A; Byrne HM
    J Theor Biol; 2016 Jun; 398():162-80. PubMed ID: 26987523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modelling, simulation and prediction of tumour-induced angiogenesis.
    Chaplain MA; Anderson AR
    Invasion Metastasis; 1996; 16(4-5):222-34. PubMed ID: 9311387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
    McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
    Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the evolution of tumor-induced microvascular network under the inhibitory effect of anti-angiogenic factor, angiostatin: A mathematical study.
    Mohammadi M; Soltani M; Aghanajafi C; Kohandel M
    Math Biosci Eng; 2023 Jan; 20(3):5448-5480. PubMed ID: 36896553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research advancement of endogenous angiogenesis inhibitors].
    Wu JX; Xu BL; Huang WL
    Ai Zheng; 2005 Mar; 24(3):376-84. PubMed ID: 15757547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer.
    Downs LS; Rogers LM; Yokoyama Y; Ramakrishnan S
    Gynecol Oncol; 2005 Aug; 98(2):203-10. PubMed ID: 15975645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.